KristAH, DavidsonKW, MangioneCM, et al.Screening for lung cancer. JAMA, 2021; 325(10):962; doi: 10.1001/jama.2021.1117
2.
MazzonePJ, SilvestriGA, SouterLH, et al.Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2021; doi: 10.1016/j.chest.2021.06.063
3.
NúñezER, TripletteM. Addressing lung cancer screening disparities: What does it mean to be centralized? Annals of the American Thoracic Society. 2022; 19(9):1457–1458; doi: 10.1513/annalsats.202206-495ed
4.
RendleKA, Burnett-HartmanAN, Neslund-DudasC, et al.Evaluating lung cancer screening across diverse healthcare systems: A process model from the lung prospr consortium. Cancer Prevention Research., 2020; 13(2):129–136; doi: 10.1158/1940-6207.capr-19-0378
5.
MazzonePJ, WhiteCS, KazerooniEA, SmithRA, ThomsonCC. Proposed quality metrics for lung cancer screening programs. Chest., 2021; 160(1):368–378; doi: 10.1016/j.chest.2021.01.063
6.
SakodaLC, RiveraMP, ZhangJ, et al.Patterns and factors associated with adherence to lung cancer screening in diverse practice settings. JAMA Network Open., 2021; 4(4):e218559; doi: 10.1001/jamanetworkopen.2021.8559
7.
KimRY, RendleKA, MitraN, et al.Racial disparities in adherence to annual lung cancer screening and recommended follow-up care: A Multicenter Cohort Study. Annals of the American Thoracic Society., 2022; 19(9):1561–1569; doi: 10.1513/AnnalsATS.202111-1253OC
8.
SaharL, Douangchai WillsVL, LiuKK, KazerooniEA, DyerDS, SmithRA. Using geospatial analysis to evaluate access to lung cancer screening in the United States. Chest., 2021; 159(2):833–844; doi: 10.1016/j.chest.2020.08.2081
9.
BartaJA, ShustedCS, RuaneB, et al.Racial differences in lung cancer screening beliefs and screening adherence. Clinical Lung Cancer., 2021; 22(6):570–578; doi: 10.1016/j.cllc.2021.06.003
10.
SmithHB, WardR, FrazierC, AngottiJ, TannerNT. Guideline-Recommended lung cancer screening adherence is superior with a centralized approach. Chest., 2022; 161(3):818–825; doi: 10.1016/j.chest.2021.09.002x
